2009-11-10 00:37:02 -
Chugai Pharmaceutical Co. Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/chugai-pharm ..
Chugai Pharmaceutical Co. Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Chugai Pharmaceutical Co., Ltd. (Chugai Pharmaceutical) is a pharmaceutical company engaged in developing medicines that suite the physical abitlity of patients as well as medicines that provide definite treatment through scientific technology that ascertains the cause of a disease. The company is headquartered in Chuo-ku, Tokyo of Japan.
In January 2009, the company´s product RoACTEMRA got approved for Rheumatoid Arthritis. In February 2009, it signed a license agreement with Romark Laboratories to develop, manufacture and distribute nitazoxanide in Japan. In April 2009, Chugai absorbed its wholly-owned subsidiary Eiko Chemicals Co., Ltd
The Chugai Pharmaceutical Co. Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
